Meningioma metastases: incidence and proposed screening paradigm
Cecilia L. Dalle Ore(Neurological Surgery), Michael McDermott(University of California, San Francisco), Philip V. Theodosopoulos(University of California, San Francisco), Stephen T. Magill(Northwestern University), Manish K. Aghi(Neurological Surgery), Javier Villanueva-Meyer(University of California, San Francisco), Calixto‐Hope G. Lucas(Johns Hopkins University), Jennifer Viner(Neurological Surgery), Adam Yen(Neurological Surgery), Maryam N. Shahin(Neurological Surgery), David S. Lee(Washington University in St. Louis), William Chen(Memorial Sloan Kettering Cancer Center), David R. Raleigh(University of California, San Francisco)
Cited by 97
Related Papers
Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience
|International Journal of Radiation Oncology*Biology*Physics|2005|421
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
|Nature Genetics|2022|296
Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach
|Neurosurgical FOCUS|2018|118
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
|Nature Medicine|2023|104